These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 649997)

  • 1. Cefamandole in the treatment of infections due to Enterobacter and indole-positive Proteus.
    Levine LR; McCain E
    J Infect Dis; 1978 May; 137 Suppl():S125-S132. PubMed ID: 649997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefamandole and cefazolin in the therapy of complicated urinary tract infections.
    Hoyme U; Madsen PO
    J Infect Dis; 1978 May; 137 Suppl():S100-S102. PubMed ID: 349091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with cefamandole for treatment of serious bone and joint infections.
    Levine LR; McCain E
    J Infect Dis; 1978 May; 137 Suppl():S119-S124. PubMed ID: 649996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial effect of cephalexin monohydrate in urinary tract infections].
    Torres J; Guevara I; Hernandez H
    Prensa Med Mex; 1970; ():65-8. PubMed ID: 4931120
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceftizoxime in the treatment of urinary tract infections.
    Plimpton HW; Crawford ED
    J Urol; 1982 Dec; 128(6):1231-2. PubMed ID: 6296465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
    Gentry LO
    J Infect Dis; 1978 May; 137 Suppl():S144-S149. PubMed ID: 349093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with cephalexin monohydrate of urinary tract infections in children. Preliminary report].
    De La Torre JA; Filloy L; Mendez Tena E; Olarte J; Torregrosa L
    Prensa Med Mex; 1970; ():87-91. PubMed ID: 4931124
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical and bacteriologic evaluation of cefamandole therapy in serious skin and skin structure infections.
    Glanges E; Crenshaw CA; Webber CE
    Surg Gynecol Obstet; 1980 Apr; 150(4):502-6. PubMed ID: 7361234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of serious infections with cefamandole.
    Parry MF; Goldberger MJ; Neu HC
    Infection; 1978; 6(5):236-40. PubMed ID: 365776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftizoxime therapy of infections in hospitalized patients and comparison with cefamandole for urinary tract infections.
    Cohen E; Mogabgab WJ
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():253-60. PubMed ID: 6296017
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo inoculum effect and resistance selection with cefamandole and cefoxitin against Enterobacter cloacae in mice.
    Miller AK; Celozzi E; Pelak BA; Birnbaum J; Stapley EO
    J Antimicrob Chemother; 1980 Nov; 6(6):804-6. PubMed ID: 7002900
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
    Guibert J; Acar JF; Justin C; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):625-7. PubMed ID: 6259607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Velocef squibb" in the treatment of respiratory and urinary infections (author's transl)].
    Gómez Francisco A
    Folia Clin Int (Barc); 1973 Sep; 23(9):616-21. PubMed ID: 4616857
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical comparison of piperacillin and cefamandole in treatment of complicated urinary tract infections.
    Resnick MI; Kursh ED
    Urology; 1987 May; 29(5):570-4. PubMed ID: 3554702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of cephalexin monohydrate in the treatment of infections of the genitourinary system].
    Aspe AJ
    Prensa Med Mex; 1970; ():45-50. PubMed ID: 4931116
    [No Abstract]   [Full Text] [Related]  

  • 16. [A double blind clinical trial of cefamandole and cefmetazole in complicated urinary tract infections].
    Ohkawa M; Hirano S; Nakashima T; Tokunaga S; Motoi I; Kuroda K; Nakamura T; Iwasa Y; Tajika E; Sakai A; Haginaka T; Kanda S; Kato M; Hasegawa M; Mikawa I; Ikeda A; Shoda R; Ejiri S; Takemae K; Kojima A; Nakajima S; Miyagi T; Ohtaki M; Kitagawa K; Kameda K; Taya T; Okumura R; Shimada K; Kobayashi T; Nango C; Okasho A; Fujita Y; Miyazaki K; Tsukahara K; Kawaguchi S; Tanaka T; Ueno K; Watanabe K
    Jpn J Antibiot; 1983 Jan; 36(1):129-49. PubMed ID: 6341653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of obstetric and gynecologic infections with cefamandole.
    Cunningham FG; Gilstrap LC; Kappus SS
    Am J Obstet Gynecol; 1979 Mar; 133(6):602-10. PubMed ID: 426015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of cephalexin monohydrate in female genitourinary infections. Report of 42 cases].
    Ricaud Rothiot L; Villalobos Roman M; Delgado Urdapilleta J
    Prensa Med Mex; 1970; ():40-1. PubMed ID: 4931115
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefamandole nafate: an evaluation of antibacterial activity, serum levels, clinical effect, and incidence of side reactions in 58 patients.
    Ekwall E; Holmgren EB; Lundbergh P; Svanbom M; Tunevall G
    Scand J Infect Dis; 1979; 11(2):135-9. PubMed ID: 462128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.
    Perkins RL; Fass RJ; Warner JF; Prior RB; File TM; Tight RR; Gardner WG; Ruiz DE; Slama TG
    J Infect Dis; 1978 May; 137 Suppl():S110-S118. PubMed ID: 418126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.